Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1.79M Buy
47,794
+19,217
+67% +$831K 1.03% 20
2022
Q1
$1.42M Buy
28,577
+4,063
+17% +$201K 0.4% 55
2021
Q4
$1.26M Buy
24,514
+22,921
+1,439% +$1.17M 0.31% 68
2021
Q3
$84.9K Sell
1,593
-509
-24% -$27.6K 0.02% 546
2021
Q2
$120K Sell
2,102
-3,182
-60% -$187K 0.03% 518
2021
Q1
$338K Sell
5,284
-15,129
-74% -$902K 0.1% 202
2020
Q4
$1.02M Sell
20,413
-41,494
-67% -$2.03M 0.3% 85
2020
Q3
$3.21M Buy
61,907
+18,327
+42% +$953K 0.93% 28
2020
Q2
$2.61M Sell
43,580
-9,348
-18% -$559K 0.7% 35
2020
Q1
$2.86M Sell
52,928
-56,658
-52% -$3.35M 0.8% 30
2019
Q4
$6.46M Buy
109,586
+29,465
+37% +$1.65M 1.2% 15
2019
Q3
$4.13M Buy
+80,121
New +$3.94M 0.74% 23
2019
Q2
Sell
-3,991
Closed -$214K 687
2019
Q1
$214K Sell
3,991
-80,217
-95% -$4.07M 0.04% 214
2018
Q4
$3.95M Buy
84,208
+6,135
+8% +$287K 0.71% 31
2018
Q3
$3.69M Buy
78,073
+75,349
+2,766% +$3.67M 0.69% 31
2018
Q2
$136K Sell
2,724
-48,742
-95% -$2.59M 0.02% 299
2018
Q1
$2.55M Buy
+51,466
New +$2.45M 0.51% 42
2017
Q4
Sell
-29,712
Closed -$1.13M 623
2017
Q3
$1.13M Buy
+29,712
New +$1.06M 0.21% 79
2017
Q2
Sell
-91,029
Closed -$3.28M 658
2017
Q1
$3.28M Buy
91,029
+88,392
+3,352% +$3.2M 0.74% 33
2016
Q4
$95.6K Buy
2,637
+980
+59% +$35.1K 0.02% 255
2016
Q3
$62.5K Sell
1,657
-24,732
-94% -$876K 0.01% 281
2016
Q2
$866K Sell
26,389
-1,062
-4% -$33.3K 0.14% 94
2016
Q1
$888K Buy
27,451
+6,860
+33% +$210K 0.12% 98
2015
Q4
$709K Buy
20,591
+7,157
+53% +$242K 0.1% 100
2015
Q3
$405K Sell
13,434
-8,398
-38% -$243K 0.05% 139
2015
Q2
$664K Buy
21,832
+3,551
+19% +$115K 0.07% 121
2015
Q1
$572K Buy
18,281
+4,046
+28% +$137K 0.06% 128
2014
Q4
$517K Buy
+14,235
New +$495K 0.07% 138

Other funds holding INTC

Exane Derivatives's INTC Position: Q2 2022 in Review

Exane Derivatives increased its Intel (INTC) stake by 67% in Q2 2022, buying an estimated $831K and bringing the position to 47,794 shares worth $1.79M. The position accounts for 1.03% of the portfolio, ranked #20.

Exane Derivatives first reported a position in INTC in Q4 2014 and has held it in 28 quarters since. The position peaked at $6.46M in Q4 2019. 2,680 funds tracked by Wall St. Rank hold INTC as of Q2 2022.

  • Exane Derivatives held 47,794 shares of Intel worth $1.79M as of Q2 2022.
  • Exane Derivatives bought 19,217 Intel shares in Q2 2022, an estimated $831K.
  • Intel made up 1.03% of Exane Derivatives's portfolio in Q2 2022, its #20 holding.
  • Exane Derivatives first reported a position in Intel in Q4 2014 and has held it in 28 quarters since.
  • Exane Derivatives's Intel position peaked at $6.46M in Q4 2019.
  • 2,680 funds tracked by Wall St. Rank held Intel as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.